Business & regional news

Two data releases at London Valves 2024 build on Evolut’s legacy of valve design and performance: Optimize PRO study demonstrates improved procedure efficiencies and valve performance Pooled...

First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease

AccuRhythm AI algorithms shown to reduce false alerts by 84%